Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • ED arrests former...

    ED arrests former Andhra Bank director in Sterling Biotech loan fraud case

    Written by Ruby Khatun Khatun Published On 2018-01-15T10:30:10+05:30  |  Updated On 15 Jan 2018 10:30 AM IST
    ED arrests former Andhra Bank director in Sterling Biotech loan fraud case
    New Delhi: A former Director of Andhra Bank has been arrested by the Enforcement Directorate (ED) in connection with its money laundering probe in the alleged Rs. 5,000-crore bank fraud case involving a Gujarat-based pharma firm, official sources said.


    They said Anup Prakash Garg was arrested by the agency late last evening.

    This is the second arrest in the case after the agency in November last year held Delhi-based businessman Gagan Dhawan from here. Garg has been arrested under the Prevention of Money Laundering Act (PMLA) and is expected to be produced before a special court. Garg has been named as an accused in the case by the ED and the CBI.


    Read also: Sterling Biotech Case: Court asks ED reply on Gagan Dhawan bail plea


    Read also: ED attaches Delhi businessman property in Sterling Biotech money laundering case


    The ED registered a money laundering case in this instance after taking cognizance of an earlier CBI FIR.


    The agency said it found during probe that “certain entries” in a diary seized by the Income Tax Department in 2011 showed various cash payments amounting to Rs. 1.52 crore made to one “Mr. Garg, Director, Andhra Bank” between 2008- 2009 by the Sandesara brothers. It said, “various cash payments were made to Garg, as reflected in the said entries, on the instructions of Sandesara brothers, by withdrawing cash from the bank accounts of several benami companies of the Sandesara brothers“.


    The ED had alleged that Garg had infused several crores of his unaccounted cash in various companies through many Kolkata based bogus shell companies with the help of cash/cheque entry operators in Kolkata to launder the proceeds of crime obtained by him from the Sandesaras.


    The CBI had booked Sterling Biotech, its directors Chetan Jayantilal Sandesara, Dipti Chetan Sandesara, Rajbhushan Omprakash Dixit, Nitin Jayantilal Sandesara and Vilas Joshi, chartered accountant Hemant Hathi, Garg and some unidentified persons in connection with the alleged bank fraud case. It had alleged that the company had taken loans of over Rs. 5,000 crores from a consortium led by Andhra Bank which had turned into non-performing assets.


    Read also: Non-bailable warrants issued against Sterling Biotech directors in Rs 5,000 crore fraud case


    The FIR had also alleged that the total pending dues of the group companies were Rs. 5,383 crore as on December 31, 2016.


    Read also: CBI FIR against Sterling Biotech for Rs 5,000 cr loan default

    Anup Prakash Gargarrestsbank fraud caseCBI)EDEnforcement DirectorateFIRformer Andhra Bank directorGagan Dhawanloan fraud casemoney laundering probePMLAPrevention of Money Laundering ActSterling Biotech
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok